Baird Financial Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-47,250
| Closed | -$227K | – | 1592 |
|
|
2019
Q4 | $227K | Hold |
47,250
| – | – | ﹤0.01% | 1431 |
|
|
2019
Q3 | $286K | Hold |
47,250
| – | – | ﹤0.01% | 1332 |
|
|
2019
Q2 | $307K | Hold |
47,250
| – | – | ﹤0.01% | 1325 |
|
|
2019
Q1 | $335K | Hold |
47,250
| – | – | ﹤0.01% | 1126 |
|
|
2018
Q4 | $230K | Hold |
47,250
| – | – | ﹤0.01% | 1182 |
|
|
2018
Q3 | $331K | Buy |
47,250
+850
| +2% | +$5.95K | ﹤0.01% | 1154 |
|
|
2018
Q2 | $296K | Hold |
46,400
| – | – | ﹤0.01% | 1142 |
|
|
2018
Q1 | $252K | Hold |
46,400
| – | – | ﹤0.01% | 1160 |
|
|
2017
Q4 | $193K | Hold |
46,400
| – | – | ﹤0.01% | 1220 |
|
|
2017
Q3 | $447K | Hold |
46,400
| – | – | ﹤0.01% | 1016 |
|
|
2017
Q2 | $549K | Hold |
46,400
| – | – | ﹤0.01% | 937 |
|
|
2017
Q1 | $595K | Hold |
46,400
| – | – | ﹤0.01% | 906 |
|
|
2016
Q4 | $568K | Buy |
+46,400
| New | +$568K | ﹤0.01% | 893 |
|